Alstadhaug KB, Ofte HK, Kristoffersen ES. Preventing and treating medication overuse headache. Pain Rep. 2017; 2: e612.Go to original source...Go to PubMed...
Evers S, Jensen R; European Federation of Neurological Societies. Treatment of medication overuse headache - guideline of the EFNS headache panel. Eur J Neurol. 2011; 18: 1115-21.Go to original source...Go to PubMed...
Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not? J Headache Pain. 2011; 12: 593-601.Go to original source...Go to PubMed...
Tassorelli C, Jensen R, Allena M, De Icco R, Sances G, Katsarava Z, Lainez M, Leston J, Fadic R, Spadafora S, Pagani M, Nappi G; the COMOESTAS Consortium. A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia 2014; 34: 645-655.Go to original source...Go to PubMed...
Westergaard ML, Munksgaard SB, Bendtsen L, Jensen RH. Medication-overuse headache: a perspective review. Ther Adv Drug Saf. 2016; 7: 147-148.Go to original source...Go to PubMed...
Castillo J, Muñoz P, Guitera V, Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 1999; 39(3): 190-196.Go to original source...Go to PubMed...
Colás R, Muñoz P, Temprano R, Gómez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 2004; 62(8): 1338-1342.Go to original source...Go to PubMed...
Coskun O, Ucler S, Cavdar L, Inan LE. Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications. J Clin Neurosci 2007; 14(4): 334-339.Go to original source...Go to PubMed...
Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007; 27(7): 814-823.Go to original source...Go to PubMed...
Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bille A. Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 1989; 236(1): 9-14.Go to original source...Go to PubMed...
Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006; 129(Pt 2): 543-550.Go to original source...Go to PubMed...
Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, Bussone G. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 2002; 42(6): 483-490.Go to original source...Go to PubMed...
Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet 1991; 337(8755): 1442-1443.Go to original source...Go to PubMed...
Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62(5): 788-790.Go to original source...Go to PubMed...
Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000; 20(2): 107-113.Go to original source...Go to PubMed...
Meng I, Dodick D, Ossipov MH, Porreca F. Pathophysiology of medication overuse headache: Insights and hypotheses from precilinical studies. Cephalalgia 2011; 3: 851-860.Go to original source...Go to PubMed...
Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001; 21(9): 878-883.Go to original source...Go to PubMed...
Prencipe M, Casini AR, Ferretti C, Santini M, Pezzella F, Scaldaferri N, Culasso F. Prevalence of headache in an elderly population: attack frequency, disability, and use of medication. J Neurol Neurosurg Psychiatry 2001; 70(3): 377-381.Go to original source...Go to PubMed...
Radat F, Creac'h C, Swendsen JD, Lafittau M, Irachabal S, Dousset V, Henry P. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005; 25(3): 165-178.Go to original source...Go to PubMed...
Reuter U, Salomone S, Ickenstein GW, Waeber C. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia. 2004; 24(5): 398-407.Go to original source...Go to PubMed...
Robinson RG. Pain relief for headaches. Is self-medication a problem? Can Fam Physician. 1993; 39: 867-868, 871-872.
Schnider P, Aull S, Baumgartner C, Marterer A, Wöber C, Zeiler K, Wessely P. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996; 16(7): 481-485.Go to original source...Go to PubMed...
Schwarz A, Faber U, Glaeske G, Keller F, Offermann G, Pommer W, Molzahn M. Analgesics consumption and analgesic-induced nephropathies in West Germany. Offentl Gesundheitswes 1985; 47(7): 298-300.Go to PubMed...
Tohyama Y, Yamane F, Fikre Merid M, Blier P, Diksic M. Effects of serotine receptors agonists, TFMPP and CGS12066B, on regional serotonin synthesis in the rat brain: an autoradiographic study. J Neurochem. 2002; 80(4): 697-705.Go to original source...Go to PubMed...
Tribl GG, Schnider P, Wöber C, Aull S, Auterith A, Zeiler K, Wessely P. Are there predictive factors for long-term outcome after withdrawal in drug-induced chronic daily headache? Cephalalgia 2001; 21(6): 691-696.Go to original source...Go to PubMed...
Williams DR, Stark RJ. Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. Cephalalgia 2003; 23(10): 963-971.Go to original source...Go to PubMed...
Madam, Sir, please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert). Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.
I declare:
that I have met the above instruction
I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited